2019
DOI: 10.1016/j.diagmicrobio.2018.12.007
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009–2017

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
69
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 68 publications
(74 citation statements)
references
References 29 publications
5
69
0
Order By: Relevance
“…However, resistance to sulphonamides is being increasingly reported; thus, it should ideally be provided in combination with two or more different kinds of antibiotics. In vitro drug sensitivity tests show that the multi-drug resistant Nocardia is sensitive to linezolid and is therefore recommended for treatment of patients with severe or disseminated disease, allergy to sulphonamides, or poor response to other drugs [ 10 , 11 ]. Meropenem was also recommended as the disease has a tendency to progress.…”
Section: Discussionmentioning
confidence: 99%
“…However, resistance to sulphonamides is being increasingly reported; thus, it should ideally be provided in combination with two or more different kinds of antibiotics. In vitro drug sensitivity tests show that the multi-drug resistant Nocardia is sensitive to linezolid and is therefore recommended for treatment of patients with severe or disseminated disease, allergy to sulphonamides, or poor response to other drugs [ 10 , 11 ]. Meropenem was also recommended as the disease has a tendency to progress.…”
Section: Discussionmentioning
confidence: 99%
“…The lung is the most frequently involved site in nocardiosis (>50%). 5,[19][20][21]49,89,160 Symptoms are nonspecific and may include cough, dyspnea, malaise, fatigue, and rarely hemoptysis. 19 As noted above, nocardiosis usually occurs in IS patients, but may occur in IC patients, particularly in those with chronic lung disease or the elderly.…”
Section: Clinical Features Pulmonarymentioning
confidence: 99%
“…include third-and fourth-generation cephalosporins (e.g., ceftriaxone, cefotaxime, and cefepime), 248 amoxicillin-clavulanate, 248 carbapenems (imipenem and meropenem), 5,20 and amikacin. 20,50,55,244 Susceptibility rates are lower with macrolides, minocycline or doxycycline, and fluoroquinolones, although these antimicrobials may have activity against some species. 50,55 Regarding the carbapenems, meropenem has been used successfully in the treatment of nocardiosis, though usually in combination with other antimicrobials.…”
Section: Antimicrobial Susceptibilitymentioning
confidence: 99%
See 2 more Smart Citations